These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 10651982)
1. Topical mevalonic acid stimulates de novo cholesterol synthesis and epidermal permeability barrier homeostasis in aged mice. Haratake A; Ikenaga K; Katoh N; Uchiwa H; Hirano S; Yasuno H J Invest Dermatol; 2000 Feb; 114(2):247-52. PubMed ID: 10651982 [TBL] [Abstract][Full Text] [Related]
2. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. Harris IR; Farrell AM; Grunfeld C; Holleran WM; Elias PM; Feingold KR J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821 [TBL] [Abstract][Full Text] [Related]
3. [Regulation of the epidermal permeability barrier by lipids and hyperproliferation]. Proksch E Hautarzt; 1992 Jun; 43(6):331-8. PubMed ID: 1628964 [TBL] [Abstract][Full Text] [Related]
4. Acceleration of de novo cholesterol synthesis in the epidermis influences desquamation of the stratum corneum in aged mice. Haratake A; Komiya A; Horikoshi T; Uchiwa H; Watanabe S Skin Pharmacol Physiol; 2006; 19(5):275-82. PubMed ID: 16778459 [TBL] [Abstract][Full Text] [Related]
5. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Man MQ; Feingold KR; Elias PM Arch Dermatol; 1993 Jun; 129(6):728-38. PubMed ID: 8507075 [TBL] [Abstract][Full Text] [Related]
6. Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis. Proksch E; Feingold KR; Elias PM J Invest Dermatol; 1992 Aug; 99(2):216-20. PubMed ID: 1629633 [TBL] [Abstract][Full Text] [Related]
7. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860 [TBL] [Abstract][Full Text] [Related]
9. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. Proksch E; Elias PM; Feingold KR J Clin Invest; 1990 Mar; 85(3):874-82. PubMed ID: 2312730 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cholesterol and sphingolipid synthesis causes paradoxical effects on permeability barrier homeostasis. Mao-Qiang M; Feingold KR; Elias PM J Invest Dermatol; 1993 Aug; 101(2):185-90. PubMed ID: 8345219 [TBL] [Abstract][Full Text] [Related]
11. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Kim M; Jung M; Hong SP; Jeon H; Kim MJ; Cho MY; Lee SH; Man MQ; Elias PM; Choi EH Exp Dermatol; 2010 Jun; 19(6):501-10. PubMed ID: 19703225 [TBL] [Abstract][Full Text] [Related]
12. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice. Ghadially R; Brown BE; Hanley K; Reed JT; Feingold KR; Elias PM J Invest Dermatol; 1996 May; 106(5):1064-9. PubMed ID: 8618040 [TBL] [Abstract][Full Text] [Related]
13. Cholesterol synthesis is required for cutaneous barrier function in mice. Feingold KR; Man MQ; Menon GK; Cho SS; Brown BE; Elias PM J Clin Invest; 1990 Nov; 86(5):1738-45. PubMed ID: 2243142 [TBL] [Abstract][Full Text] [Related]
14. The regulation of epidermal lipid synthesis by permeability barrier requirements. Feingold KR Crit Rev Ther Drug Carrier Syst; 1991; 8(3):193-210. PubMed ID: 1954650 [TBL] [Abstract][Full Text] [Related]
15. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. Holleran WM; Man MQ; Gao WN; Menon GK; Elias PM; Feingold KR J Clin Invest; 1991 Oct; 88(4):1338-45. PubMed ID: 1918384 [TBL] [Abstract][Full Text] [Related]
16. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. Ghadially R; Brown BE; Sequeira-Martin SM; Feingold KR; Elias PM J Clin Invest; 1995 May; 95(5):2281-90. PubMed ID: 7738193 [TBL] [Abstract][Full Text] [Related]
17. Localization and regulation of epidermal 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by barrier requirements. Proksch E; Elias PM; Feingold KR Biochim Biophys Acta; 1991 Apr; 1083(1):71-9. PubMed ID: 2031940 [TBL] [Abstract][Full Text] [Related]
18. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963 [TBL] [Abstract][Full Text] [Related]
19. Barrier function regulates epidermal lipid and DNA synthesis. Proksch E; Holleran WM; Menon GK; Elias PM; Feingold KR Br J Dermatol; 1993 May; 128(5):473-82. PubMed ID: 8504036 [TBL] [Abstract][Full Text] [Related]
20. Fatty acids are required for epidermal permeability barrier function. Mao-Qiang M; Elias PM; Feingold KR J Clin Invest; 1993 Aug; 92(2):791-8. PubMed ID: 8102380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]